4D Molecular 制药

US · FDMT #3519 按市值排名上市于 2020

12.14 -0.73 -5.67%

实时 - 追踪5344个代码 - 心跳于472秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量增加了2家。
机构持股总比例下降了0.8个百分点。

机构持股

机构持股比例: 106.56% -0.76pp
机构数量: 190 +2
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund49.76%

Hedge Fund27.02%

VC/PE Fund17.60%

Public Company9.60%

Individual/Insider2.84%

Private Company1.39%

Insurance Company0.89%

Government Pension Fund0.25%

主要股东截至 2026-06-30

Janus Henderson Group plc 10.40% · 5.75M 股

RA Capital Management, L.P. 9.14% · 5.05M 股

BlackRock 8.23% · 4.55M 股

The Goldman Sachs Group, Inc. 6.95% · 3.84M 股

Novo Holdings A/S 5.88% · 3.25M 股

State Street Global Advisors 5.27% · 2.91M 股

BVF Partners L.P. 5.21% · 2.88M 股

T. Rowe Price Group, Inc. 4.65% · 2.57M 股

Vanguard Capital Management, LLC 4.30% · 2.38M 股

Adage Capital Management, L.P. 4.07% · 2.25M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 20次买入 · 25次卖出

姓名	职务	持股比例
David Kirn	Chief Executive Officer	2.48%
John Milligan	Executive Chairperson	0.18%
Ashoo Gupta	Principal Accounting Officer & Principal Financial Officer	0.09%
Charles Theuer	Independent Director	0.08%
Scott Bizily	Chief Legal & Human Resources Officer and Corporate Secretary	0.02%
Fariborz Kamal	President	0.01%
Glenn Sblendorio	Director	--
Robert Kim	Chief Medical Officer	--
BVF Partners L.P.	--	--
RA Capital Management, L.P.	--	--

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-10-04	David Kirn	Chief Executive Officer	Intent to Sell (Form 144)	-58,333	$12.92
2026-09-15	Scott Bizily	Chief Legal & Human Resources Officer and Corporate Secretary	Derivative Exercise and Sale	-1,635	$4.14–13.65
2026-09-13	David Kirn	Chief Executive Officer	Automatic Disposition	-58,333	$13.90
2026-08-31	Scott Bizily	Chief Legal & Human Resources Officer and Corporate Secretary	Derivative Exercise and Sale	-584	$6.49–14.00
2026-08-18	David Kirn	Chief Executive Officer	Automatic Disposition	-19,076	$16.42
2026-08-18	David Kirn	Chief Executive Officer	Derivative Exercise and Sale	-50,000	$4.14–16.42
2026-08-16	Scott Bizily	Chief Legal & Human Resources Officer and Corporate Secretary	Derivative Exercise and Sale	-3,270	$4.14–12.20
2026-08-03	David Kirn	Chief Executive Officer	Automatic Disposition	-26,842	$10.23
2026-08-02	David Kirn	Chief Executive Officer	Automatic Disposition	-12,415	$10.05
2026-07-09	David Kirn	Chief Executive Officer	Open Market Disposition	-58,333	$12.01–12.87
2026-07-09	David Kirn	Chief Executive Officer	Intent to Sell (Form 144)	-15,725	$12.31
2026-07-08	David Kirn	Chief Executive Officer	Intent to Sell (Form 144)	-42,608	$12.89
2026-06-29	Scott Bizily	Chief Legal & Human Resources Officer and Corporate Secretary	Derivative Exercise and Sale	-6,566	$4.14–14.00
2026-06-22	Scott Bizily	Chief Legal & Human Resources Officer and Corporate Secretary	Derivative Exercise and Sale	-9,810	$4.14–12.00
2026-06-21	David Kirn	Chief Executive Officer	Automatic Disposition	-114,746	$10.47
2026-06-16	Glenn Sblendorio	Director	Other Derivative Acquisition	+50,000	$9.42
2026-06-16	John Milligan	Executive Chairperson	Other Derivative Acquisition	+75,000	$9.42
2026-06-16	Charles Theuer	Independent Director	Other Derivative Acquisition	+50,000	$9.42
2026-06-16	Susannah Gray	Independent Director	Other Derivative Acquisition	+50,000	$9.42
2026-06-16	Jacob Chacko	Independent Director	Other Derivative Acquisition	+50,000	$9.42

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。